These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37083067)

  • 1. Paclitaxel induces pyroptosis by inhibiting the volume‑sensitive chloride channel leucine‑rich repeat‑containing 8a in ovarian cancer cells.
    Yang X; Li C; Liao X; Liu S; Li X; Hou X; Wang K; Yang H; Gao L; Zhu L
    Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37083067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ClC-3 promotes paclitaxel resistance via modulating tubulins polymerization in ovarian cancer cells.
    Feng J; Peng Z; Gao L; Yang X; Sun Z; Hou X; Li E; Zhu L; Yang H
    Biomed Pharmacother; 2021 Jun; 138():111407. PubMed ID: 33765585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation.
    Zhang CC; Li CG; Wang YF; Xu LH; He XH; Zeng QZ; Zeng CY; Mai FY; Hu B; Ouyang DY
    Apoptosis; 2019 Apr; 24(3-4):312-325. PubMed ID: 30710195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal paclitaxel induces apoptosis, cell death, inhibition of migration capacity and antitumoral activity in ovarian cancer.
    Faria RS; de Lima LI; Bonadio RS; Longo JPF; Roque MC; de Matos Neto JN; Moya SE; de Oliveira MC; Azevedo RB
    Biomed Pharmacother; 2021 Oct; 142():112000. PubMed ID: 34426249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume-activated chloride channels contribute to lipopolysaccharide plus nigericin-induced pyroptosis in bone marrow-derived macrophages.
    Ye X; Liu X; Wei W; Yu H; Jin X; Yu J; Li C; Xu B; Guo X; Mao J
    Biochem Pharmacol; 2021 Nov; 193():114791. PubMed ID: 34582774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of green tea extract and paclitaxel in the induction of mitochondrial apoptosis in ovarian cancer cell lines.
    Panji M; Behmard V; Zare Z; Malekpour M; Nejadbiglari H; Yavari S; Nayerpour Dizaj T; Safaeian A; Bakhshi A; Abazari O; Abbasi M; Khanicheragh P; Shabanzadeh M
    Gene; 2021 Jun; 787():145638. PubMed ID: 33848578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo.
    Kong QW; Yang J; Li D; Ding YW; Hu YJ; Xue XC; Shi MZ; Jiang B; Zhou YY; Zhang M; Hu JD; Guo C; Chen JJ; Han YL
    J Ethnopharmacol; 2023 Jan; 300():115728. PubMed ID: 36126783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WWOX promotes apoptosis and inhibits autophagy in paclitaxel‑treated ovarian carcinoma cells.
    Zhao Y; Wang W; Pan W; Yu Y; Huang W; Gao J; Zhang Y; Zhang S
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CBL0137 activates ROS/BAX signaling to promote caspase-3/GSDME-dependent pyroptosis in ovarian cancer cells.
    Yang C; Wang ZQ; Zhang ZC; Lou G; Jin WL
    Biomed Pharmacother; 2023 May; 161():114529. PubMed ID: 37002567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells.
    Dai C; Xu P; Liu S; Xu S; Xu J; Fu Z; Cao J; Lv M; Zhou J; Liu G; Zhang H; Jia X
    Arch Gynecol Obstet; 2021 May; 303(5):1271-1281. PubMed ID: 33151424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of piperine and paclitaxel on cell fate via cyt-c, Bax/Bcl-2-caspase-3 pathway in ovarian adenocarcinomas SKOV-3 cells.
    Pal MK; Jaiswar SP; Srivastav AK; Goyal S; Dwivedi A; Verma A; Singh J; Pathak AK; Sankhwar PL; Ray RS
    Eur J Pharmacol; 2016 Nov; 791():751-762. PubMed ID: 27756602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gallic acid sensitizes paclitaxel-resistant human ovarian carcinoma cells through an increase in reactive oxygen species and subsequent downregulation of ERK activation.
    Sánchez-Carranza JN; Díaz JF; Redondo-Horcajo M; Barasoain I; Alvarez L; Lastres P; Romero-Estrada A; Aller P; González-Maya L
    Oncol Rep; 2018 Jun; 39(6):3007-3014. PubMed ID: 29693189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kuguacin J isolated from bitter melon leaves modulates paclitaxel sensitivity in drug-resistant human ovarian cancer cells.
    Pitchakarn P; Umsumarng S; Mapoung S; Ting P; Temviriyanukul P; Punfa W; Pompimon W; Limtrakul P
    J Nat Med; 2017 Oct; 71(4):693-702. PubMed ID: 28639112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted inhibition of phosphatidyl inositol-3-kinase p110β, but not p110α, enhances apoptosis and sensitivity to paclitaxel in chemoresistant ovarian cancers.
    Jeong JY; Kim KS; Moon JS; Song JA; Choi SH; Kim KI; Kim TH; An HJ
    Apoptosis; 2013 Apr; 18(4):509-20. PubMed ID: 23371322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of dexamethasone on the proliferation and apoptosis of human ovarian cancer cells induced by paclitaxel.
    Hou W; Guan J; Lu H; Dong Q; Han Y; Zhang R
    J Ovarian Res; 2014 Sep; 7():89. PubMed ID: 25297825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.
    Wang L; Jia E
    Drug Deliv; 2016 Jun; 23(5):1810-7. PubMed ID: 26530693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
    Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
    Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
    [No Abstract]   [Full Text] [Related]  

  • 18. Disruption of protein neddylation with MLN4924 attenuates paclitaxel-induced apoptosis and microtubule polymerization in ovarian cancer cells.
    Hong X; Li S; Li W; Xie M; Wei Z; Guo H; Wei W; Zhang S
    Biochem Biophys Res Commun; 2019 Jan; 508(3):986-990. PubMed ID: 30545630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A natural product, voacamine, sensitizes paclitaxel-resistant human ovarian cancer cells.
    Pellegrini E; Multari G; Gallo FR; Vecchiotti D; Zazzeroni F; Condello M; Meschini S
    Toxicol Appl Pharmacol; 2022 Jan; 434():115816. PubMed ID: 34856211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
    Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
    Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.